The 60-second version
PFAS — per- and polyfluoroalkyl substances — are a class of about 15,000 synthetic chemicals manufactured since the 1940s. The carbon-fluorine bond at their core is one of the strongest in chemistry. They do not meaningfully break down in nature, in conventional drinking-water treatment, or in the human body. Hence the nickname forever chemicals.
In April 2024, the EPA finalized the first-ever enforceable U.S. drinking water limits for six PFAS. For PFOA and PFOS — the two most-studied compounds — the limit is 4 parts per trillion, the lowest concentration the agency considers technically measurable. Utilities have until 2029 to comply.
PFAS are detectable in the blood of more than 97% of Americans. The U.S. Geological Survey detected at least one PFAS in 45% of tap-water samples nationwide in 2023. The health concerns most strongly supported by evidence are kidney and testicular cancer, immune suppression (especially reduced vaccine antibody response in children), thyroid disease, elevated cholesterol, and pregnancy-induced hypertension. Other claims you'll see — broader endocrine disruption, ADHD, fertility effects — range from "biologically plausible and under active study" to "not well supported by current evidence." We'll be specific about which is which.
Why "forever"
The defining chemistry: a backbone of carbon atoms with fluorine attached at almost every available position. The C–F bond requires roughly 500 kJ/mol to break — comparable to the bonds that hold diamond together. That bond is what gives PFAS their useful properties (heat resistance, water repellence, non-stick) and what makes them an environmental nightmare.
In the environment, PFAS cycle through soil, groundwater, surface water, sediment, and atmospheric deposition. They literally rain down — long-chain PFAS volatilize into the atmosphere from industrial sources and ocean spray, then deposit thousands of miles away in remote watersheds.
In the body, the long-chain PFAS most studied (PFOA, PFOS, PFHxS, PFNA) have multi-year elimination half-lives. PFOA: about 2.3 years. PFOS: about 5 years. This means that even after exposure stops, blood levels decline slowly.
Where it comes from
PFAS exposure is not primarily a tap-water story — for most Americans, food packaging and consumer products contribute as much as or more than water. But water is the exposure route that public policy can move on, which is why the regulatory conversation centers there.
The dominant water sources:
- Firefighting foam ("AFFF") used at military bases, civilian airports, and refinery sites. AFFF was sprayed in vast volumes during training exercises through the 1970s, 80s, and 90s. Almost every U.S. military installation has a documented AFFF plume.
- Industrial discharge from manufacturers (especially the DuPont/Chemours, 3M, and Solvay plants, but also dozens of smaller fluorochemical processors and end-users).
- Landfill leachate. PFAS from disposed consumer products leaches out of landfills and re-enters water.
- Biosolids spread as fertilizer. Sewage sludge ("biosolids") spread on farmland concentrates PFAS in soil and groundwater. Maine has begun banning biosolids application after discovering widespread agricultural contamination.
- Atmospheric deposition. Documented for PFOA and short-chain compounds globally, including in remote Arctic sites.
What the science says — graded
The EPA's regulatory decision rests on a long evidence base. But not every PFAS claim you'll see online has the same level of support. Here's how the strongest claims grade out:
Strongly supported
- Kidney and testicular cancer. Multiple cohort studies (including the C8 Health Project of ~70,000 Ohio Valley residents exposed via DuPont discharge) show clear dose-response. IARC classifies PFOA as Group 1 ("carcinogenic to humans") and PFOS as Group 2B ("possibly carcinogenic").
- Reduced vaccine antibody response in children. Demonstrated in Faroe Islands and Norwegian cohort studies. This is the basis for the immune-suppression concern.
- Elevated serum cholesterol. Consistent across multiple populations.
- Pregnancy-induced hypertension and pre-eclampsia. Multiple high-quality cohorts.
- Thyroid disease. Multiple studies show association, particularly with PFOA.
Moderately supported
- Reduced fetal growth / low birth weight. Most studies show small effects; some show null. Trend supports modest impact.
- Liver enzyme elevation. Consistent in animal studies and observational human data, though clinical significance varies.
- Ulcerative colitis. C8 Health Project found this association; replication elsewhere has been mixed.
Plausible but not well-established
- Adult cancer types beyond kidney and testicular. Suggestive evidence for breast, prostate, and pancreatic, but not as robust.
- ADHD and other neurodevelopmental outcomes. Some studies show associations, others null. Confounding is hard.
- Adult fertility effects. Some signals; not consistent.
Not well supported by current evidence
- That PFAS at typical drinking-water concentrations are a major driver of any specific disease at the population level. Background blood levels in the U.S. have actually declined for PFOA and PFOS since voluntary industry phaseouts. The risk concentrates in heavily-exposed communities, not the median U.S. drinker.
The new rule, plainly
In April 2024, EPA set Maximum Contaminant Levels for six PFAS:
| Compound | MCL | MCLG (health goal) |
|---|---|---|
| PFOA | 4.0 ng/L (ppt) | 0 |
| PFOS | 4.0 ng/L (ppt) | 0 |
| PFHxS | 10 ng/L | 10 |
| HFPO-DA (GenX) | 10 ng/L | 10 |
| PFNA | 10 ng/L | 10 |
| Mixtures of PFHxS, HFPO-DA, PFNA, PFBS | Hazard Index = 1 | 1 |
The PFOA/PFOS limits are striking because they're set at the limit of measurement. EPA's position is, in effect, that any detectable PFOA or PFOS is too much, and the regulation should be set as close to "non-detect" as is technically feasible.
Utilities had until 2027 to begin initial monitoring, and until 2029 to comply with the MCLs if they exceed them. As of 2026, most utilities have not yet completed their first round of compliance sampling. Your report today probably does not reflect what your utility will report by 2029.
A consortium of water utilities sued to block the rule in 2024 on the grounds that the cost (~$1.5 billion annually) is not proportional to the benefit. The litigation is ongoing; as of this writing, the rule stands.
What you can actually do
The good news: PFAS removal from drinking water is technically straightforward at the household scale.
- Reverse osmosis units (NSF/ANSI 58). The most reliable point-of-use option. Removes >99% of common PFAS.
- Granular activated carbon certified to NSF/ANSI 53 with P473. P473 is the PFAS-specific certification. Most carbon filters without P473 will remove some PFAS but performance degrades faster than for other contaminants.
- Ion exchange resins. Used at the utility scale and increasingly available in residential cartridges.
What does not work for PFAS:
- Boiling (concentrates them)
- Standard pitcher filters certified only to NSF/ANSI 42 (taste/odor)
- "Activated carbon" without the P473 cert
- Bottled water (often not tested, may be just as high)
If you live within a few miles of a military base with a known AFFF plume, a major airport, a Superfund site, or a fluorochemical manufacturing facility — the testing and filtration case is much stronger.
What the science doesn't yet tell you
This is the part most articles skip. Three honest unknowns:
-
The short-chain replacement PFAS (GenX, ADONA, F-53B) were marketed as safer because they leave the body faster. Animal studies show they have similar toxicities. The human cohort data is much thinner. We do not yet know whether replacement-PFAS exposure at typical levels translates to the same disease burden.
-
Co-exposure interactions. Almost every blood sample contains a mixture of dozens of PFAS plus other persistent organics. Whether the health risk of any single compound is modified by the presence of others is barely studied.
-
Long-term outcomes at the new regulatory levels. No one has population-level evidence on what happens to disease incidence after 20 years of sub-4-ppt PFOA exposure. The 4 ppt limit is a best-available extrapolation, not a measured threshold.
Sources
- EPA. PFAS National Primary Drinking Water Regulation (Final Rule, April 2024).
- USGS. PFAS in U.S. Tap Water (2023).
- ATSDR. Toxicological Profile for Perfluoroalkyls.
- NIEHS. Perfluorinated Chemicals (PFAS).
- EWG. PFAS Contamination in the U.S. (interactive map).
Corrections welcome at corrections@waterawarenessinitiative.com.
More from Contaminants Explained.
Pharmaceuticals in tap water: what's actually been detected, what it does, and the brutally honest gap in what we know
Antidepressants, hormones, blood pressure meds, painkillers, antibiotics, chemo agents — all detected in U.S. public water supplies. Concentrations are tiny. The honest answer about long-term effects in 2026: we still don't know. Here is what is actually documented, what is plausible, and what is hype.
Fluoride: the science, the controversy, and the 2024 NTP review that changed the conversation
Community water fluoridation has been one of the most successful public-health interventions of the 20th century. It is also under more sustained scientific scrutiny than at any point in 70 years. Here is what the evidence shows, what the 2024 NTP monograph actually concluded, and why both anti-fluoride and pro-fluoride absolutism mislead readers.
Lead in drinking water: what the science actually says, and what to do tomorrow morning
Roughly 9 million American homes still get water through lead pipes. Here is what lead does to a developing brain, why your utility's compliance report is not the same as your tap, and the specific steps that reduce exposure now.
Get one Sunday email like this — sourced, calm, no spam.
We send a single weekly digest summarizing what changed in U.S. drinking water that week. Free, one-click unsubscribe.